News
Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...
Scientists at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Milan, have found that gene editing using ...
Artificial blood could reduce preventable deaths in settings where limited supply costs millions of lives in low-income ...
Rusfertide (Protagonist Therapeutics/Takeda Pharmaceuticals) — administered as a once-weekly subcutaneous injection — also ...
The only difference is where the cancer cells are found. In CLL, most of the cancer cells are in the blood and bone marrow. In SLL, the cancer cells are mainly in the lymph nodes and spleen. Both CLL ...
Introduction The global blood products market is experiencing steady growth due to several key drivers. A major factor is the increasing number ...
Cell and gene therapies harbor great hopes for biomedicine. They are becoming increasingly important for diseases that are ...
He is suing for negligence after 17-year-old Braxton Gilpin, who had Hemophilia B, died from an untreated brain bleed while ...
A man’s acquired hemophilia coincided with a rare liver disease, a connection that had not been reported before, per a case ...
Scientists working at the NIH’s BRAIN Initiative have created new viral vectors that one day could lead to gene therapies for ...
In this document we present recommendations from the Infectious Diseases Committee of the Brazilian Association of Hematology, Blood Transfusion and Cell Therapy (ABHH) for the management of febrile ...
A therapy to boost the production of regulatory T-cells prevented inhibitor formation in a mouse model of hemophilia A, per a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results